AstraZeneca, Ranbaxy Ask 1st Circ. To Affirm Nexium Win
AstraZeneca PLC and Ranbaxy Inc. told the First Circuit on Friday that it should affirm a Massachusetts federal court's ruling that purchasers of AstraZeneca's blockbuster heartburn drug Nexium couldn't get a...To view the full article, register now.
Already a subscriber? Click here to view full article